Collier N A, Weinbren K, Bloom S R, Lee Y C, Hodgson H J, Blumgart L H
Lancet. 1984 Mar 10;1(8376):538-40. doi: 10.1016/s0140-6736(84)90934-6.
Serum neurotensin concentrations were supranormal in 5 out of 20 patients with carcinoma of the liver. Liver specimens from 4 of these 5 patients demonstrated features typical of fibrolamellar carcinoma. Neurotensin may be suitable as a tumour marker for fibrolamellar carcinoma and may be useful for the detection of recurrences after treatment.
